Tieton Capital Management, LLC / MYGN
Tieton Capital Management, LLC’s Myriad Genetics Inc Position
Does Tieton Capital Management, LLC own Myriad Genetics Inc (MYGN)? Not currently — the last reported position was 118.5K shares worth $3M in Q4 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q4 2021
Shares
118.5K
% of Portfolio
+1.83%
Quarters Held
13
position exited
Position History MYGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2021 | 118.5K | $3M | +1.83% |
| Q3 2021 | 129.4K | $4M | +2.27% |
| Q2 2021 | 133.2K | $4M | +2.17% |
| Q1 2021 | 183.1K | $6M | +3.21% |
| Q4 2020 | 187.6K | $4M | +2.72% |
| Q3 2020 | 194.0K | $3M | +2.50% |
| Q2 2020 | 166.4K | $2M | +2.36% |
| Q1 2020 | 164.7K | $2M | +3.79% |
| Q4 2019 | 181.0K | $5M | +3.94% |
| Q3 2019 | 171.8K | $5M | +4.19% |
| Q2 2019 | 160.4K | $4M | +3.90% |
| Q1 2019 | 98.2K | $3M | +2.90% |
| Q4 2018 | 12.0K | $348,000 | +0.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tieton Capital Management, LLC’s full portfolio or all institutional holders of MYGN.